Skip to main content
AstraZeneca PLC (LON:AZN)
London flag London · Delayed Price · Currency is GBP · Price in GBX
11,000
+44 (0.40%)
Sep 26, 2025, 5:06 PM BST

AstraZeneca Revenue

AstraZeneca had revenue of $14.46B USD in the quarter ending June 30, 2025, with 11.74% growth. This brings the company's revenue in the last twelve months to $56.50B, up 15.00% year-over-year. In the year 2024, AstraZeneca had annual revenue of $54.07B with 18.03% growth.

Revenue (ttm)
$56.50B
Revenue Growth
+15.00%
P/S Ratio
4.14
Revenue / Employee
$599.16K
Employees
94,300
Market Cap
170.58B GBP

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202454.07B8.26B18.03%
Dec 31, 202345.81B1.46B3.29%
Dec 31, 202244.35B6.93B18.53%
Dec 31, 202137.42B10.80B40.58%
Dec 31, 202026.62B2.23B9.16%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
GSK plc 31.63B
Haleon 11.02B
Smith & Nephew 4.33B
ConvaTec Group 1.72B
Hikma Pharmaceuticals 2.35B
HUTCHMED (China) 439.54M
Genus 672.80M
Oxford Nanopore Technologies 204.69M
Revenue Rankings

AstraZeneca News

More News